296 related articles for article (PubMed ID: 28318644)
21. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
[TBL] [Abstract][Full Text] [Related]
22. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer.
Tanderup K; Fokdal LU; Sturdza A; Haie-Meder C; Mazeron R; van Limbergen E; Jürgenliemk-Schulz I; Petric P; Hoskin P; Dörr W; Bentzen SM; Kirisits C; Lindegaard JC; Pötter R
Radiother Oncol; 2016 Sep; 120(3):441-446. PubMed ID: 27350396
[TBL] [Abstract][Full Text] [Related]
23. Point-Based Brachytherapy in Cervical Cancer With Limited Residual Disease: A Low- and Middle-Income Country Experience in the Era of Magnetic Resonance-Guided Adaptive Brachytherapy.
Gupta A; Dey T; Rai B; Oinam AS; Gy S; Ghoshal S
JCO Glob Oncol; 2021 Sep; 7():1602-1609. PubMed ID: 34843375
[TBL] [Abstract][Full Text] [Related]
24. Clinical feasibility of interstitial brachytherapy using a "hybrid" applicator combining uterine tandem and interstitial metal needles based on CT for locally advanced cervical cancer.
Liu ZS; Guo J; Lin X; Wang HY; Qiu L; Ren XJ; Li YF; Zhang BY; Wang TJ
Brachytherapy; 2016; 15(5):562-9. PubMed ID: 27474180
[TBL] [Abstract][Full Text] [Related]
25. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
[TBL] [Abstract][Full Text] [Related]
26. Inverse Planned High-Dose-Rate Brachytherapy for Locoregionally Advanced Cervical Cancer: 4-Year Outcomes.
Tinkle CL; Weinberg V; Chen LM; Littell R; Cunha JAM; Sethi RA; Chan JK; Hsu IC
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1093-1100. PubMed ID: 26194683
[TBL] [Abstract][Full Text] [Related]
27. Transrectal ultrasound for image-guided adaptive brachytherapy in cervix cancer - An alternative to MRI for target definition?
Schmid MP; Nesvacil N; Pötter R; Kronreif G; Kirisits C
Radiother Oncol; 2016 Sep; 120(3):467-472. PubMed ID: 26921168
[TBL] [Abstract][Full Text] [Related]
28. Risk of Late Urinary Complications Following Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: Refining Bladder Dose-Volume Parameters.
Manea E; Escande A; Bockel S; Khettab M; Dumas I; Lazarescu I; Fumagalli I; Morice P; Deutsch E; Haie-Meder C; Chargari C
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):411-420. PubMed ID: 29559282
[TBL] [Abstract][Full Text] [Related]
29. Three-dimensional high dose rate intracavitary image-guided brachytherapy for the treatment of cervical cancer using a hybrid magnetic resonance imaging/computed tomography approach: feasibility and early results.
Beriwal S; Kannan N; Kim H; Houser C; Mogus R; Sukumvanich P; Olawaiye A; Richard S; Kelley JL; Edwards RP; Krivak TC
Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):685-90. PubMed ID: 21908180
[TBL] [Abstract][Full Text] [Related]
30. Retrospective analysis of local recurrence pattern by computed tomography image-guided intracavitary and interstitial brachytherapy for locally advanced cervical cancer in a single Japanese institution.
Umezawa R; Tokunaga H; Yamamoto T; Shigeta S; Takahashi N; Takeda K; Suzuki Y; Kishida K; Ito K; Kadoya N; Shimada M; Jingu K
Brachytherapy; 2023; 22(4):477-486. PubMed ID: 37208225
[TBL] [Abstract][Full Text] [Related]
31. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
Chen CC; Wang L; Lin JC; Jan JS
J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
[TBL] [Abstract][Full Text] [Related]
32. Computed tomography-based image-guided brachytherapy for cervical cancer: correlations between dose-volume parameters and clinical outcomes.
Kusada T; Toita T; Ariga T; Maemoto H; Hashimoto S; Shiina H; Kakinohana Y; Heianna J; Nagai Y; Kudaka W; Aoki Y; Murayama S
J Radiat Res; 2018 Jan; 59(1):67-76. PubMed ID: 29186565
[TBL] [Abstract][Full Text] [Related]
33. Comparison of computed tomography and magnetic resonance imaging in cervical cancer brachytherapy target and normal tissue contouring.
Eskander RN; Scanderbeg D; Saenz CC; Brown M; Yashar C
Int J Gynecol Cancer; 2010 Jan; 20(1):47-53. PubMed ID: 20130502
[TBL] [Abstract][Full Text] [Related]
34. Value of Magnetic Resonance Imaging Without or With Applicator in Place for Target Definition in Cervix Cancer Brachytherapy.
Pötter R; Federico M; Sturdza A; Fotina I; Hegazy N; Schmid M; Kirisits C; Nesvacil N
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):588-97. PubMed ID: 26867887
[TBL] [Abstract][Full Text] [Related]
35. Change in image-guided planning strategies over time impacts oncologic and survival outcomes for intracavitary cervical cancer brachytherapy.
D'Cunha P; Gonzalez Y; Nwachukwu C; Hrycushko B; Medin P; Owrangi A; Jia X; Albuquerque K
Brachytherapy; 2022; 21(5):668-677. PubMed ID: 35871130
[TBL] [Abstract][Full Text] [Related]
36. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
Wang X; Liu R; Ma B; Yang K; Tian J; Jiang L; Bai ZG; Hao XY; Wang J; Li J; Sun SL; Yin H
Cochrane Database Syst Rev; 2010 Jul; (7):CD007563. PubMed ID: 20614461
[TBL] [Abstract][Full Text] [Related]
37. Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: A mono-institutional experience.
Lakosi F; de Cuypere M; Viet Nguyen P; Jansen N; Warlimont B; Gulyban A; Gennigens C; Seidel L; Delbecque K; Coucke P; Hermesse J; Kridelka F
Acta Oncol; 2015; 54(9):1558-66. PubMed ID: 26406152
[TBL] [Abstract][Full Text] [Related]
38. The use of MRI deformable image registration for CT-based brachytherapy in locally advanced cervical cancer.
Tait LM; Hoffman D; Benedict S; Valicenti R; Mayadev JS
Brachytherapy; 2016; 15(3):333-340. PubMed ID: 26882845
[TBL] [Abstract][Full Text] [Related]
39. [Clinical results of combined intracavitary-interstitial image-guided adaptive brachytherapy in locally advanced cervical cancer].
Vízkeleti J; Fröhlich G; Nhung NA; Horváth K; Major T; Polgár C
Magy Onkol; 2018 Dec; 62(4):249-257. PubMed ID: 30540868
[TBL] [Abstract][Full Text] [Related]
40. Dose-volume effects in pathologic lymph nodes in locally advanced cervical cancer.
Bacorro W; Dumas I; Escande A; Gouy S; Bentivegna E; Morice P; Haie-Meder C; Chargari C
Gynecol Oncol; 2018 Mar; 148(3):461-467. PubMed ID: 29325690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
